NCT01416662View on ClinicalTrials.gov

Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

September 30, 2015

Conditions
Pancreatic Cancer
Interventions
DRUG

gemcitabine hydrochloride

Trial Locations (1)

13385

CHU de la Timone, Marseille

All Listed Sponsors
lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT01416662 - Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | Biotech Hunter | Biotech Hunter